EmmanuelBenjaminWalterMD
Pediatrics • Durham, NCProfessor, Pediatrics, Duke University School of Medicine Chief Medical Officer, Duke Human Vaccine Institute
Dr. Walter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Vaccine and Trials Unit @ RTP
27 Alexandria Way
Durham, NC 27703Phone+1 919-620-5346
Education & Training
Duke University HospitalResidency, Pediatrics, 1987 - 1990
University of MarylandResidency, Pediatrics, 1983 - 1987
University of Maryland School of MedicineClass of 1983
Certifications & Licensure
NC State Medical License 1987 - 2025
MD State Medical License 1984 - 1987
American Board of Pediatrics Pediatrics
Clinical Trials
- Alternate Dosing Schedules Study for HPV Vaccine Start of enrollment: 2009 Mar 01
- Home Administration of FluMist by Parents/Caregivers Start of enrollment: 2014 Sep 01
- Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.Hana M El Sahly, Evan J Anderson, Lisa A Jackson, Kathleen M Neuzil, Robert L Atmar
Vaccine. 2025-02-15 - Evaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults.Lindsay Boole, Zhonghui Yang, Stephen P Bergin, Robert M Tighe, Emily Randolph
Antimicrobial Agents and Chemotherapy. 2025-02-13 - 1 citationsNeutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen
Clinical Infectious Diseases. 2025-02-05
Journal Articles
- Reactogenicity and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant and Nonpregnant Women☆Kimberly B Fortner, Geeta K Swamy, M Anthony Moody, Sandra Yoder, Kathryn M Edwards, Emmanuel B Walter, R Phillips Heine, ScienceDirect
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza SeasonEmmanuel Walter, MD, Centers for Disease Control and Prevention
Press Mentions
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu ShotsNovember 11th, 2024- Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu ShotsNovember 8th, 2024
- It’s Safe to Get the COVID-19 and Flu Shots at the Same TimeNovember 6th, 2024
- Join now to see all
Grant Support
- Piiitch StudyNational Center For Immunization And Respiratory Diseases2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
